{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:22:19Z","timestamp":1787887339728,"version":"build-2784847793"},"reference-count":40,"publisher":"BMJ","issue":"6","funder":[{"name":"Viatris","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014756","name":"Hexal AG","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100014756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2026,2,5]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) and highly active disease may benefit from early post partum reinitiation of disease-modifying therapy (DMT), but safety data to monoclonal antibody (mAb) use while breastfeeding are limited. This study examined infant development and health following potential mAb exposure during breastfeeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective monocentric cohort study of infants, born in 2013\u20132022, in the German MS and Pregnancy Registry, followed up 6\u201336 months post partum via telephone interviews. 183 infants breastfed during maternal mAb therapy (mAb use during breastfeeding (mAb-BF)) were matched 1:1 (DMT pregnancy exposure) to infants of DMT-na\u00efve mothers (no-DMT-BF). Primary outcomes included developmental delay, systemic antibiotic use, hospitalisation, severe infection and growth. Adjusted regression models estimated the beta coefficient, OR or rate ratio with 95% CI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 366 infants. Among 183 mAb-BF infants, most were breastfed on natalizumab (n=125), followed by ocrelizumab (n=34), rituximab (n=11) and ofatumumab (n=10); three had multiple exposures. Developmental delays occurred in 8.2% mAb-BF and in 7.1% no-DMT-BF infants (p=0.844). A comparable number of infants used a systemic antibiotic (n=33\/183, 18.0% vs n=29\/183, 15.8%; p=0.676), were hospitalised (n=18\/183, 9.8% vs 19\/183, 10.4%; p=1.000) or had a severe infection (n=14\/183, 7.7% vs n=13\/183, 7.1%; p=1.000). The physical growth and adjusted model outcomes were also similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results indicate that infants of mothers with neuroimmunological diseases, breastfed under mAbs, did not experience negative consequences for their development and health within the initial 6\u201336 months of life. This may encourage mothers with highly active disease to breastfeed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-338092","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T18:20:40Z","timestamp":1772216440000},"page":"522-531","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Safety of breastfeeding under monoclonal antibodies in the offspring of mothers with multiple sclerosis or neuromyelitis optica spectrum disorder"],"prefix":"10.1136","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4902-3521","authenticated-orcid":false,"given":"Laura","family":"Witt","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Friedmann","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Haben","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dost-Kovalsky","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"},{"name":"Institute of Social Medicine and Epidemiology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9762-1315","authenticated-orcid":false,"given":"Nadine","family":"Bast","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"},{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Oganowski","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Thiel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-9011","authenticated-orcid":false,"given":"Kerstin","family":"Hellwig","sequence":"additional","affiliation":[{"name":"Department of Neurology, Katholisches Klinikum Bochum Sankt Josef-Hospital, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"2026051402050508000_97.6.522.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00426-4"},{"key":"2026051402050508000_97.6.522.2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-332804"},{"key":"2026051402050508000_97.6.522.3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331525"},{"key":"2026051402050508000_97.6.522.4","unstructured":"World Health Organization . Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals. Geneva: WHO Press, 2009."},{"key":"2026051402050508000_97.6.522.5","unstructured":"Bennett P . Drugs and human lactation: a comprehensive guide to the content and consequences of drugs, micronutrients, radiopharmaceuticals and environmental and occupational chemicals in human milk. Amsterdam: Elsevier, 1996."},{"key":"2026051402050508000_97.6.522.6","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000637","article-title":"Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions","volume":"7","author":"Krysko","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026051402050508000_97.6.522.7","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions","volume":"10","author":"Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"2026051402050508000_97.6.522.8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/13524585241307165","article-title":"Ofatumumab-exposed breastfeeding in multiple sclerosis patients","volume":"31","author":"Witt","year":"2025","journal-title":"Mult Scler"},{"key":"2026051402050508000_97.6.522.9","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000723","article-title":"Monoclonal antibody treatment during pregnancy and\/or lactation in women with MS or neuromyelitis optica spectrum disorder","volume":"7","author":"Ciplea","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2026051402050508000_97.6.522.10","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211054956","article-title":"The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results","volume":"14","author":"Thiel","year":"2021","journal-title":"Ther Adv Neurol Disord"},{"key":"2026051402050508000_97.6.522.11","first-page":"106","article-title":"Elternfrageb\u00f6gen zu Grenzsteinen der kindlichen Entwicklung im Alter von 1 bis 6 Jahren","volume":"84","author":"Nennstiel-Ratzel","year":"2013","journal-title":"Kinder\u00e4rztliche Praxis"},{"key":"2026051402050508000_97.6.522.12","unstructured":"Biogen Inc . TYSABRI (natalizumab) injection, for intravenous use. 2025. Available: https:\/\/www.tysabri.com\/content\/dam\/commercial\/tysabri\/pat\/en_us\/pdf\/tysabri_prescribing_information.pdf"},{"key":"2026051402050508000_97.6.522.13","unstructured":"EMA . Ocrevus\u00ae (ocrelizumab) - EPAR summary of product characteristics. 2024. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ocrevus-epar-product-information_en.pdf"},{"key":"2026051402050508000_97.6.522.14","unstructured":"EMA . Kesimpta\u00ae (ofatumumab) - EPAR summary of product characteristics. n.d. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/kesimpta-epar-product-information_en.pdf"},{"key":"2026051402050508000_97.6.522.15","unstructured":"EMA . MabThera\u00ae (rituximab) - EPAR summary of product characteristics. 2024. Available: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mabthera-epar-product-information_en.pdf"},{"key":"2026051402050508000_97.6.522.16","unstructured":"Gemeinsamer Bundesausschuss (G-BA) . Fr\u00fcherkennung bei kindern. n.d. Available: https:\/\/www.g-ba.de\/themen\/methodenbewertung\/kinder"},{"key":"2026051402050508000_97.6.522.17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/CLEP.S392273","article-title":"Maternal Multiple Sclerosis and Health Outcomes Among the Children: A Systematic Review","volume":"15","author":"Andersen","year":"2023","journal-title":"Clin Epidemiol"},{"key":"2026051402050508000_97.6.522.18","doi-asserted-by":"crossref","first-page":"104867","DOI":"10.1016\/j.msard.2023.104867","article-title":"Interferon-beta exposure in-utero and the risk of infections in early childhood","volume":"77","author":"Windfeld-Mathiasen","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2026051402050508000_97.6.522.19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"2026051402050508000_97.6.522.20","unstructured":"Greiner W , Batram M , Hasemann L , et al . Kinder-und jugendreport. Nordrhein Westfalen, 2019."},{"key":"2026051402050508000_97.6.522.21","unstructured":"DAK-Gesundheit . Kinder-Und Jugendreport 2020: Schwerpunkt Corona-Pandemie: Folgen F\u00fcr Die Krankenhausversorgung von Kindern Und Jugendlichen. Heidelberg: medhochzwei Verlag GmbH, 2020."},{"key":"2026051402050508000_97.6.522.22","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514546790"},{"key":"2026051402050508000_97.6.522.23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329657"},{"key":"2026051402050508000_97.6.522.24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101137","article-title":"Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry","volume":"48","author":"Bast","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"2026051402050508000_97.6.522.25","doi-asserted-by":"crossref","first-page":"104087","DOI":"10.1016\/j.msard.2022.104087","article-title":"Fetal and post-natal growth in infants of mothers with multiple sclerosis: A case-control stud","volume":"65","author":"Marozio","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2026051402050508000_97.6.522.26","unstructured":"Blank R . Deutsch-\u00f6sterreichisch-schweizerische (dach) versorgungsleitlinie zu definition, diagnostik, behandlung und psychosozialen aspekten bei umschriebenen entwicklungsst\u00f6rungen motorischer funktionen (uemf), langfassung. arbeitsgemeinschaft der wissenschaftlichen medizinischen fachgesellschaften (awmf online). 2020 Available: https:\/\/register.awmf.org\/assets\/guidelines\/022-017l_S3_Umschriebene-Entwicklungsstoerungen-motorischer-Funktionen-UEMF_2020-08_01.pdf"},{"key":"2026051402050508000_97.6.522.27","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221079598"},{"key":"2026051402050508000_97.6.522.28","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s10072-025-08188-6","article-title":"Long-term safety evaluation of natalizumab during pregnancy and lactation in patients with multiple sclerosis","volume":"46","author":"Carrozzo","year":"2025","journal-title":"Neurol Sci"},{"key":"2026051402050508000_97.6.522.29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1352458520904545","article-title":"Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis","volume":"27","author":"Mahlanza","year":"2021","journal-title":"Mult Scler"},{"key":"2026051402050508000_97.6.522.30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/IYC.0000000000000056","article-title":"Parent Recognition and Responses to Developmental Concerns in Young Children","volume":"29","author":"Marshall","year":"2016","journal-title":"Infants & Young Children"},{"key":"2026051402050508000_97.6.522.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2011.01.001"},{"key":"2026051402050508000_97.6.522.32","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100758","article-title":"Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci"},{"key":"2026051402050508000_97.6.522.33","first-page":"9","article-title":"Rituximab: an insider\u2019s historical perspective","volume":"27","author":"Grillo-L\u00f3pez","year":"2000","journal-title":"Semin Oncol"},{"key":"2026051402050508000_97.6.522.34","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.377"},{"key":"2026051402050508000_97.6.522.35","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.00130","article-title":"Partial Degradation of Recombinant Antibody Functional Activity During Infant Gastrointestinal Digestion: Implications for Oral Antibody Supplementation","volume":"7","author":"Sah","year":"2020","journal-title":"Front Nutr"},{"key":"2026051402050508000_97.6.522.36","doi-asserted-by":"crossref","first-page":"106136","DOI":"10.1016\/j.msard.2024.106136","article-title":"175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results","volume":"92","author":"Hellwig","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2026051402050508000_97.6.522.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.09.003"},{"key":"2026051402050508000_97.6.522.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.105924"},{"key":"2026051402050508000_97.6.522.39","unstructured":"EUROCAT . Guide 1.5 and reference documents. 2022. Available: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/data-collection\/guidelines-for-data-registration_en#inline-nav-2"},{"key":"2026051402050508000_97.6.522.40","unstructured":"Neuhauser H , Schienkiewitz A , Schaffrath Rosario A , et al . Beitr\u00e4ge Zur Gesundheitsberichterstattung Des Bundes \u2011 Referenzperzentile F\u00fcr Anthropometrische Ma\u00dfzahlen Und Blutdruck Aus Der Studie Zur Gesundheit von Kindern Und Jugendlichen in Deutschland (KiGGS). Robert Koch-Institut, 2013."}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-338092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:05:34Z","timestamp":1778749534000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-338092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jnnp-2025-338092"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-338092","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}